Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026
Same author

Clinical and molecular characterization of familial hypocalciuric hypercalcemia in an endocrine practice: a case series of 25 patients.

JBMR plus·2026
Same author

The Modern Presentation, Etiology, and Rate of Occurrence of Cushing Syndrome Differs when Compared to Prior Population-Based Studies.

AACE endocrinology and diabetes·2026
Same author

Development and implementation of an innovative mentoring committee for early-career faculty members.

Surgery·2026
Same author

Surgical Trainee Familiarity and Knowledge of the Commission on Cancer Operative Standards: A National Survey Study.

Journal of the American College of Surgeons·2026
Same author

Adrenalectomy patients with mixed primary aldosteronism and hypercortisolism: An analysis of outcomes following surgery at a single institution.

Surgery·2025
Same journal

ASO Author Reflections: The Hidden Cost of Gastric Preservation During Cytoreductive Surgery for Pseudomyxoma Peritonei: Understanding the Functional Consequences of Extensive Perigastric Cytoreduction.

Annals of surgical oncology·2026
Same journal

Survival of Squamous Cell Carcinoma Versus Adenocarcinoma in Resected Stage I-III Non-small Cell Lung Cancer.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Quality, Reliability, and Viewer Engagement of YouTube Videos on Esophageal Cancer: A Cross-Sectional Study.

Annals of surgical oncology·2026
Same journal

ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.

Annals of surgical oncology·2026
Same journal

Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery and Increased Use of Radiation.

Annals of surgical oncology·2026
Same journal

The Impact of Tumor Size on Therapeutic Decision-Making for Upper Tract Urothelial Carcinoma: A Large-Scale Population Analysis.

Annals of surgical oncology·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

462

Landmark Studies in Differentiated Thyroid Cancer.

Sarah B Fisher1, Tracy S Wang2

  • 1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sfisher@mdanderson.org.

Annals of Surgical Oncology
|May 9, 2025
PubMed
Summary
This summary is machine-generated.

Surgical resection is the primary treatment for differentiated thyroid cancer (DTC). Ongoing research explores active surveillance and targeted therapies for advanced or unresectable DTC, aiming to improve patient outcomes.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.5K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.6K

Related Experiment Videos

Last Updated: May 4, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

462
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.5K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.6K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Endocrinology

Background:

  • Differentiated thyroid cancer (DTC) management relies heavily on surgical resection.
  • Adjuvant therapies like radioactive iodine ablation and TSH suppression are standard for DTC.
  • Limited data exists on long-term outcomes for alternative DTC strategies like active surveillance.

Purpose of the Study:

  • To review landmark studies guiding current surgical management of DTC.
  • To highlight controversies and novel therapeutics impacting DTC surgical care.
  • To inform multidisciplinary treatment approaches for advanced or unresectable DTC.

Main Methods:

  • Literature review of key studies in DTC surgical management.
  • Analysis of current guidelines and emerging therapeutic strategies.
  • Focus on controversies and innovations in DTC treatment.

Main Results:

  • Surgical resection is the cornerstone of curative-intent therapy for DTC.
  • Active surveillance and ablation are options for very low-risk DTC, but long-term data is scarce.
  • Targeted therapies and understanding mutation profiles are crucial for advanced/unresectable DTC.

Conclusions:

  • Surgical management remains central to differentiated thyroid cancer treatment.
  • Further research is needed for long-term outcomes of alternative DTC strategies.
  • Multidisciplinary approaches incorporating targeted therapies are essential for complex DTC cases.